Immusoft Competitors and Similar CompaniesClear all
Immusoft's competitors and similar companies include Acorda Therapeutics and Polyplus-transfection.
 Acorda Therapeutics Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. |  Polyplus-transfection Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics. | ||
Founding Date | Founding Date 2009 | Founding Date 1995 | Founding Date 2002 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Seattle, US HQ San Francisco, US | Locations Ardsley, US HQ Chelsea, US South San Francisco, US Waltham, US | Locations Illkirch-Graffenstaden, FR HQ New York, US |
Employees | Employees 22 | Employees 4742% decrease | Employees 1133% increase |
Funding | |||
Latest funding round | Latest funding round $ 3.6m (over 8 years ago) | Latest funding round N/A | Latest funding round $ 3.2m (over 15 years ago) |
Total funding raised | Total funding raised $ 9.4m | Total funding raised N/A | Total funding raised $ 3.2m |
For sources of this data, please see the company profile
View Company Profiles
Acorda Therapeutics
HQ
Ardsley, US
Employees
474↓ 2% decrease
Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.
View companyPolyplus-transfection
HQ
Illkirch-Graffenstaden, FR
Employees
113↑ 3% increase
Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics.
View company